AcuityBio is a privately-held company based in the Greater Boston area. AcuityBio is commercializing a first in class therapeutic drug delivery technology, which has wide applicability. AcuityBio has developed a drug-eluting implant that reduces the incidence of locoregional lung cancer recurrence by locally delivering therapeutic levels of drug to the site of disease for over several months.